President Trump's administration directed $50 million in federal funding toward accelerating research into psychedelic treatments like psilocybin to help combat the rising number of U.S. adults suffering from treatment-resistant depression.
Politics
·
New reasons not to be depressed about depression
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Rejecting closer EU ties would be dereliction of duty, PM to say
Image source, Bloomberg via Getty ImagesByChris MasonPolitical editorPublished58 minutes agoThe prime minister is expect...
CitrixNews Staff
·
3 hours ago
Politics
Three signs that America is on the run
These three events show how vulnerable bases and infrastructure can be to remote attacks.
CitrixNews Staff
·
3 hours ago
Politics
Federal Judge Bars Trump Administration From Airing Publicly Funded Ads
A group of liberal organizations sued last week over the ads that praised the administration.
CitrixNews Staff
·
4 hours ago
Politics
Top Senate Republican calls Guilfoyle reports ‘very troubling’
Sen. John Barrasso (R-Wyo.), the Senate Majority Whip, on Sunday expressed concern about the recent reporting on U.S. Am...
CitrixNews Staff
·
5 hours ago